688553 匯宇製藥
按盤價 
12.320 +1.230 (+11.091%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.540 | -0.645 | 8.398 | 3.733 | 6.844 |
| 總資產報酬率 ROA (%) | 1.128 | -0.490 | 6.606 | 3.119 | 5.924 |
| 投入資產回報率 ROIC (%) | 1.262 | -0.547 | 7.341 | 3.471 | 6.657 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.745 | 79.603 | 83.414 | 85.929 | 88.202 |
| 營業利潤率 (%) | 8.702 | -6.635 | 31.838 | 13.415 | 15.767 |
| 息稅前利潤/營業總收入 (%) | 4.124 | -11.329 | 29.933 | 9.746 | 12.824 |
| 淨利潤/營業總收入 (%) | 10.340 | -3.060 | 28.865 | 15.029 | 16.674 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 162.348 | -115.615 | 25.107 | 40.379 | 79.263 |
| 價值變動淨收益/利潤總額(%) | -76.628 | 258.932 | 72.540 | 30.739 | 18.969 |
| 營業外收支淨額/利潤總額(%) | 2.636 | -2.973 | 0.362 | 5.892 | 1.235 | 償債能力分析 |
| 流動比率 (X) | 2.430 | 2.687 | 2.942 | 3.264 | 5.458 |
| 速動比率 (X) | 2.210 | 2.463 | 2.801 | 3.090 | 5.143 |
| 資產負債率 (%) | 28.557 | 25.352 | 23.080 | 19.447 | 13.058 |
| 帶息債務/全部投入資本 (%) | 17.482 | 14.448 | 12.782 | 10.295 | 1.708 |
| 股東權益/帶息債務 (%) | 460.208 | 578.047 | 672.970 | 863.990 | 5,704.069 |
| 股東權益/負債合計 (%) | 250.969 | 295.327 | 333.743 | 413.795 | 665.802 |
| 利息保障倍數 (X) | -0.857 | 2.319 | -14.809 | -2.161 | -4.083 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 37.723 | 26.373 | 18.070 | 19.179 | 6.594 |
| 存貨周轉天數 (天) | 399.391 | 374.572 | 310.428 | 440.314 | 352.322 |
| 備註： | 即時報價更新時間為 21/09/2026 15:35 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
